NCT00268515View on ClinicalTrials.gov

Aerosol Cyclosporine for Prevention of Lung Rejection

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 1998

Study Completion Date

March 31, 2003

Conditions
Lung Diseases
Interventions
DRUG

cyclosporine

DRUG

tacrolimus

DRUG

prednisone

DRUG

azathioprine

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00268515 - Aerosol Cyclosporine for Prevention of Lung Rejection | Biotech Hunter | Biotech Hunter